Intensified multifactorial intervention and cardiovascular outcome in type 2 diabetes: the Steno-2 study (Q35206390)

7 August 2017

1 reference

title

Intensified multifactorial intervention and cardiovascular outcome in type 2 diabetes: the Steno-2 study (English)

1 reference

7 August 2017

1 reference

Oluf Pedersen

1

1 reference

PubMed ID

12939735

7 August 2017

Peter Gaede

series ordinal

2

1 reference

7 August 2017

1 August 2003

1 reference

7 August 2017

1 reference

7 August 2017

52

1 reference

7 August 2017

8 Suppl 1

1 reference

7 August 2017

19-23

1 reference

The effect of interventions to prevent cardiovascular disease in patients with type 2 diabetes mellitus

7 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900213-0

Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900213-0

Limited impact of lifestyle education in patients with Type 2 diabetes mellitus and microalbuminuria: results from a randomized intervention study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900213-0

Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900213-0

n-3 Polyunsaturated fatty acids, fatal ischemic heart disease, and nonfatal myocardial infarction in older adults: the Cardiovascular Health Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900213-0

Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41). United Kingdom Prospective Diabetes Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900213-0

The cost-effectiveness of lipid lowering in patients with diabetes: results from the 4S trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900213-0

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900213-0

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900213-0

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900213-0

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900213-0

Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900213-0

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900213-0

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900213-0

Final report on the aspirin component of the ongoing Physicians' Health Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900213-0

Exercise and the metabolic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900213-0

Randomised controlled trial of structured personal care of type 2 diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900213-0

10.1016/S0026-0495(03)00213-0

7 January 2021

Identifiers

DOI

1 reference

7 August 2017

1 reference

PubMed ID

12939735